Diet and intestinal microbiota alterations

Assessment and comparison of the effects of two types of low calorie low carbohydrate and low fat diets on intestinal microbiota changes and its association with some of metabolic factors alterations in obese women

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200929048876N3

Enrollment

Registered

2021-01-08

Start date

2021-01-09

Completion date

Unknown

Last updated

2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity. Obesity due to excess calories

Interventions

Intervention 1: Intervention and control group: From the total daily calorie needs, 500 kcal per day will be reduce for 0.5 kg weight reduction in each patient. In low fat diet 20% of total daily calo

Eligibility

Sex/Gender

Female

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Body mass index equal or higher than 30 female ages of 18 to 50 year

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Waist circumference alterarions. Timepoint: baseline and after 6 weeks. Method of measurement: centimeter.;Intestinal microbiota alterations. Timepoint: baseline and after 6 weeks. Method of measurement: autoanalyzer setting.;Blood pressure alterations. Timepoint: baseline and after 6 weeks. Method of measurement: autoanalyzer setting.;C-reactive protein alterations. Timepoint: baseline and after 6 weeks. Method of measurement: ELIZA kit.;Serum insulin alterations. Timepoint: baseline and after 6 weeks. Method of measurement: ELIZA kit.;Hip circumference alterations. Timepoint: baseline and after 6 weeks. Method of measurement: centimeter.;Weight alterations. Timepoint: baseline and after 6 weeks. Method of measurement: scale.;Fasting blood sugar alterations. Timepoint: baseline and after 6 weeks. Method of measurement: autoanalyzer setting.;Fasting triglyceride alterations. Timepoint: baseline and after 6 weeks. Method of measurement: autoanalyzer setting.;Total cholesterol alterations. Timepoint: baseline and after 6 weeks. Method of measurement: autoanalyzer setting.;LDL.C cholesterol alterations. Timepoint: baseline and after 6 weeks. Method of measurement: autoanalyzer setting.;HDL.C cholesterol alterations. Timepoint: baseline and after 6 weeks. Method of measurement: autoanalyzer setting.	—

Measure

Time frame

Waist circumference alterarions. Timepoint: baseline and after 6 weeks. Method of measurement: centimeter.;Intestinal microbiota alterations. Timepoint: baseline and after 6 weeks. Method of measurement: autoanalyzer setting.;Blood pressure alterations. Timepoint: baseline and after 6 weeks. Method of measurement: autoanalyzer setting.;C-reactive protein alterations. Timepoint: baseline and after 6 weeks. Method of measurement: ELIZA kit.;Serum insulin alterations. Timepoint: baseline and after 6 weeks. Method of measurement: ELIZA kit.;Hip circumference alterations. Timepoint: baseline and after 6 weeks. Method of measurement: centimeter.;Weight alterations. Timepoint: baseline and after 6 weeks. Method of measurement: scale.;Fasting blood sugar alterations. Timepoint: baseline and after 6 weeks. Method of measurement: autoanalyzer setting.;Fasting triglyceride alterations. Timepoint: baseline and after 6 weeks. Method of measurement: autoanalyzer setting.;Total cholesterol alterations. Timepoint: baseline and after 6 weeks. Method of measurement: autoanalyzer setting.;LDL.C cholesterol alterations. Timepoint: baseline and after 6 weeks. Method of measurement: autoanalyzer setting.;HDL.C cholesterol alterations. Timepoint: baseline and after 6 weeks. Method of measurement: autoanalyzer setting.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mahnaz Karbalaei

Zanjan University of Medical Sciences

karbalaei.mahnaz@yahoo.com+98 24 3315 6300

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 18, 2026